Angel investors are playing an increasingly prominent role in supporting young biotechs and health care companies, according to a new study from the University of New Hampshire’s Center for Venture Research.
The Oct. 10 report indicated that 36% of angel investments – equity investments made by high-net-worth individuals typically in start-ups – went to U.S. health care and biotechnology companies during...